Insider Shareholders with Direct Ownership of Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a comprehensive overview of the insiders with direct ownership of Catalyst Pharmaceuticals, Inc. (CPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CATALYST PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Patrick J Mcenany
Director |
2,688,699 | 2,979,693 | 4,481,702 $94.4 Million | 49 |
Dec 09, 2024
Added 0.08%
|
|
Steve Miller
Chief Op. & Scientific Officer |
983,205 | 718,896 | 921,996 $19.4 Million | 23 |
Dec 13, 2024
Added 20.31%
|
|
Charles B O'Keeffe
Director |
349,731 | 0 | 727,137 $15.3 Million | 14 |
Dec 10, 2024
Added 5.21%
|
|
Donald A Denkhaus
Director |
254,746 | 40,000 | 439,746 $9.27 Million | 14 |
Dec 09, 2024
Added 0.32%
|
|
David S Tierney
Director |
254,746 | 210,000 | 350,287 $7.38 Million | 23 |
Dec 09, 2024
Added 0.4%
|
|
Richard J Daly
President and CEO |
253,333 | 18,509 | 234,824 $4.95 Million | 13 |
Jun 04, 2024
Reduced 6.87%
|
|
Philip H Coelho
Director |
148,000 | 158,540 | 204,887 $4.32 Million | 17 |
May 04, 2023
Added 19.62%
|
|
Brian Elsbernd
Chief Compliance/Legal Officer |
292,066 | 115,542 | 176,524 $3.72 Million | 19 |
Dec 09, 2024
Reduced 0.96%
|
|
Gary Ingenito
Chief Med. & Reg. Officer |
653,349 | 597,500 | 55,849 $1.18 Million | 30 |
Dec 09, 2024
Reduced 4.92%
|
|
Alicia Grande
VP, Treasurer and CFO |
633,832 | 974,365 | 55,813 $1.18 Million | 34 |
Dec 27, 2023
Reduced 5.76%
|
|
Preethi Sundaram
Chief Strategy Officer |
121,854 | 91,873 | 29,981 $631,699 | 12 |
Dec 09, 2024
Reduced 7.45%
|
|
Jeffrey Del Carmen
Chief Commercial Officer |
291,195 | 244,862 | 18,053 $380,376 | 22 |
Dec 09, 2024
Reduced 11.54%
|
|
Molly Harper
Director |
38,246 | 36,833 | 1,413 $29,771 | 9 |
Dec 09, 2024
Added 50.0%
|
|
Tamar Thompson
Director |
1,413 | 0 | 1,413 $29,771 | 1 |
Dec 09, 2024
Added 50.0%
|